Search

Your search keyword '"Bogati S"' showing total 1 results
Start Over Author "Bogati S" Topic pyridazines

Refine your results

1 results on '"Bogati S"'

1. Safe and effective use of ponatinib in a patient with chronic myeloid leukemia and acute venous thromboembolism on therapeutic anti-coagulation.

Author

Shomali W, Redmond C, Bogati S, Zimmerman C, Visconte V, Tabarroki A, Kalaycio M, and Tiu RV

Subjects
Adult, Antineoplastic Agents administration & dosage, Antineoplastic Agents adverse effects, Disease Progression, Humans, Imidazoles administration & dosage, Imidazoles adverse effects, Leukemia, Myelogenous, Chronic, BCR-ABL Positive complications, Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis, Male, Protein Kinase Inhibitors administration & dosage, Protein Kinase Inhibitors adverse effects, Pyridazines administration & dosage, Pyridazines adverse effects, Treatment Outcome, Venous Thromboembolism diagnosis, Anticoagulants therapeutic use, Antineoplastic Agents therapeutic use, Imidazoles therapeutic use, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Protein Kinase Inhibitors therapeutic use, Pyridazines therapeutic use, Venous Thromboembolism drug therapy, Venous Thromboembolism etiology
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results